Adecatumumab
|
WikiDoc Resources for Adecatumumab |
|
Articles |
|---|
|
Most recent articles on Adecatumumab Most cited articles on Adecatumumab |
|
Media |
|
Powerpoint slides on Adecatumumab |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Adecatumumab at Clinical Trials.gov Clinical Trials on Adecatumumab at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Adecatumumab
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Adecatumumab Discussion groups on Adecatumumab Patient Handouts on Adecatumumab Directions to Hospitals Treating Adecatumumab Risk calculators and risk factors for Adecatumumab
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Adecatumumab |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview
Adecatumumab is a human monoclonal antibody which it's used to target tumor cells. It binds to the epithelial cell adhesion molecule (EpCAM).
External links